Clinical Report: Dry Eye Dx and Tx: Tech’s Role in Modern Dry Eye Diagnostics

Overview

Technological advancements are enhancing the objectivity and efficiency of dry eye disease evaluations. Noninvasive methods like NIBUT and tear osmolarity measurements are becoming essential in diagnosing dry eye disease, leading to improved patient outcomes.

Background

Dry eye disease (DED) presents a significant challenge in clinical practice due to its multifactorial nature and variable symptoms. Traditional diagnostic methods often lack reproducibility and correlation with patient-reported symptoms. The integration of advanced technologies promises to improve diagnostic accuracy and treatment personalization.

Data Highlights

No numerical data available in the source material.

Key Findings

• Noninvasive tear breakup time (NIBUT) is recommended over fluorescein TBUT for DED diagnosis.
• Tear osmolarity values exceeding 308 mOsm/L indicate tear film instability.
• The MMP-9 point-of-care test is useful for identifying ocular surface inflammation but may yield false negatives in mild cases.
• Interferometry can assess lipid layer thickness, crucial for diagnosing evaporative DED.
• AI algorithms are being developed to automate the interpretation of diagnostic images, enhancing consistency.
• Wearable tear sensors and smart contact lenses are under development for real-time monitoring of tear film biomarkers.

Clinical Implications

Clinicians should consider incorporating advanced diagnostic technologies into their practice to enhance the accuracy of dry eye disease evaluations. Utilizing objective measurements alongside patient symptom assessments can lead to more targeted treatments and improved patient care.

Conclusion

The evolution of technology in dry eye diagnostics is transforming the field from subjective assessments to data-driven methodologies, promising better management of dry eye disease.

References

1. Sullivan BD, et al, Acta Ophthalmol, 2014 -- Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications
2. Wolffsohn JS, et al, Am J Ophthalmol, 2025 -- TFOS DEWS III Diagnostic Methodology
3. Mejía-Salgado G, et al, Graefes Arch Clin Exp Ophthalmol, 2025 -- Real-world performance of the inflammadry test in dry eye diagnosis: an analysis of 1,515 patients
4. Li J, et al, BMC Ophthalmol, 2020 -- Assessment of tear film lipid layer thickness in patients with Meibomian gland dysfunction
5. Persiya J, Sasithradevi A, J Contact Lens Spectrum, 2024 -- Thermal mapping the eye: A critical review of advances in infrared imaging for disease detection
6. Contact Lens Spectrum — Dry Eye Dx and Tx
7. Contact Lens Spectrum — Dry Eye Dx and Tx
8. Contact Lens Spectrum — Dry Eye Dx and Tx
9. Contact Lens Spectrum — Dry Eye Dx and Tx
10. TFOS DEWS III: Diagnostic Methodology
11. Real-world performance of the inflammadry test in dry eye diagnosis
12. Development and multicenter validation of an AI driven model for quantitative meibomian gland evaluation